Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Journal of Neuroimmunology
Journal
Overview
Identity
Overview
Publication Venue For
Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease
. 309:100-110.
2017
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis
. 297:1-8.
2016
IFNγ inhibits Th17 differentiation and function via Tbet-dependent and Tbet-independent mechanisms
. 267:20-27.
2014
Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis
. 273:85-95.
2014
IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis
. 263:43-54.
2013
The complement anaphylatoxin receptors are not required for the development of experimental autoimmune uveitis
. 264:127-129.
2013
Sex hormone-dependent attenuation of EAE in a transgenic mouse with astrocytic expression of the RNA regulator HuR
. 246:34-37.
2012
Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS
. 243:81-88.
2012
Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis
. 223:92-99.
2010
Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis
. 220:99-103.
2010
Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome
. 219:54-63.
2010
Erratum to "The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial" [J. Neuroimmunol. 201-202(2008)80-84] (DOI:10.1016/j.jneuroim.2008.05.031)
. 217:103.
2009
Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen
. 217:51-54.
2009
Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis
. 206:22-27.
2009
Expression and function of SOCS proteins in astrocytes
. 203:215-215.
2008
The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial
. 201-202:80-84.
2008
Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats
. 195:47-59.
2008
Identification of pyruvate kinase as an antigen associated with Tourette syndrome
. 181:165-176.
2006
Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation
. 179:132-144.
2006
Regulation of CD8
+
cytolytic T lymphocyte differentiation by a cholinergic pathway
. 164:66-75.
2005
CRH stimulates POMC activity and corticosterone production in dermal fibroblasts
. 162:97-102.
2005
Neuroimaging in human immunodeficiency virus infection
. 157:153-162.
2004
An IgM anti-MBP Ab in a case of Waldenstrom's macroglobulinemia with polyneuropathy expressing an idiotype reactive with an MBP epitope immunodominant in MS and EAE
. 113:163-169.
2001
Highly related immunoglobulin light chain sequences in different multiple sclerosis patients
. 100:98-101.
1999
Adhesion molecule expression and regulation on cells of the central nervous system
. 98:77-88.
1999
Interleukin-6 expression and regulation in astrocytes
. 100:124-139.
1999
HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues
. 92:152-159.
1998
Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-κB and C/EBP isoforms
. 92:196-207.
1998
Kinase inhibitors abrogate IFN-γ-induced class II transactivator and class II MHC gene expression in astroglioma cell lines
. 85:174-185.
1998
Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes
. 78:47-56.
1997
Induction of RANTES expression by astrocytes and astrocytoma cell lines
. 71:207-214.
1996
Preferential association of Vλx light chains with γ2a heavy chains in naturally occurring human myelin basic protein reactive antibodies
. 70:15-20.
1996
The kinetics of ACTH expression in rat leukocyte subpopulations
. 63:103-112.
1995
Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity
. 59:57-63.
1995
Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes
. 51:209-220.
1994
Role of arcuate nucleus of the hypothalamus in the acquisition of association memory between the CS and US
. 50:109-114.
1994
Fine-specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells
. 48:221-226.
1993
Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine
. 45:137-145.
1993
The identity of the unconditioned stimulus to the central nervous system is interferon-β
. 45:75-81.
1993
The structure of a myelin basic protein-associated idiotope
. 46:235-243.
1993
Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein
. 39:231-242.
1992
Immune processing of proteolipid protein by subsets of antigen-presenting spleen cells
. 38:139-146.
1992
Interferon-gamma regulation of C3 gene expression in human astroglioma cells
. 38:275-282.
1992
Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells
. 36:179-191.
1992
Corticotropin-releasing factor upregulates expression of two truncated pro-opiomelanocortin transcripts in murine lymphocytes
. 31:51-58.
1991
Expression of immunoreactive growth hormone in leukocytes in vivo
. 33:43-54.
1991
Functional assessment and partial characterization of [
3
H](+)-pentazocine binding sites on cells of the immune system
. 35:153-166.
1991
Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway
. 28:53-61.
1990
Immunomodulatory characteristics of a novel antiproliferative protein, suppressin
. 30:179-187.
1990
Immunoreactive growth hormone-releasing hormone in rat leukocytes
. 29:1-13.
1990
Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-γ and tumor necrosis factor-α
. 30:189-200.
1990
Induction and regulation of interleukin-6 gene expression in rat astrocytes
. 30:201-212.
1990
Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine
. 26:25-34.
1990
The development and characterization of encephalitogenic cloned T cells specific for myelin proteolipid protein
. 26:139-145.
1990
Tumor necrosis factor production and receptor expression by a human malignant glioma cell line, D54-MG
. 30:1-13.
1990
Interleukin-2 induction of ACTH secretion: presence of an interleukin-2 receptor α-chain-like molecule on pituitary cells
. 21:249-254.
1989
Monoclonal idiotypic and anti-idiotypic antibodies produced by immunization with peptides specified by a region of human myelin basic protein mRNA and its complement
. 22:157-166.
1989
The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein
. 21:183-191.
1989
Tumor necrosis factor-α enhances interferon-γ-mediated class II antigen expression on astrocytes
. 25:209-219.
1989
Response of human glioblastoma cells to recombinant interleukin-2
. 17:301-314.
1988
An antibody to a peptide specified by an RNA that is complementary to γ-endorphin mRNA recognizes an opiate receptor
. 12:329-337.
1986
Neuroendocrine peptide hormones and their receptors in the immune system. production, processing and action
. 10:31-40.
1985
Identity
International Standard Serial Number (issn)
0165-5728
Electronic International Standard Serial Number (eissn)
1872-8421